Distributor inventory | Tablet
Teneligliptin 20 mg + Metformin Hydrochloride 500 mg (as sustained/extended release) tablet
Type 2 diabetes mellitus: to improve blood glucose control in adults when diet and exercise are not sufficient; used alone or with other antidiabetic medicines as prescribed.
Teneligliptin is a DPP-4 inhibitor that increases incretin hormones (GLP-1, GIP), leading to increased insulin release and reduced glucagon in a glucose-dependent manner. Metformin reduces glucose production by the liver and improves insulin sensitivity, thereby lowering blood sugar levels.
Take by mouth exactly as prescribed. Typically taken once daily with/after food (preferably with the main meal) to reduce stomach upset; swallow whole (do not crush/chew if SR/ER). Dose adjustments are based on blood sugar control and kidney function.
Common side effects of TENEWAY M 500MG TAB may include:
Not for type 1 diabetes or diabetic ketoacidosis. Metformin can rarely cause lactic acidosis—risk increases with kidney disease, severe dehydration, sepsis, heavy alcohol use, liver disease, or hypoxia/heart failure; assess renal function before and during therapy. Temporarily stop metformin before iodinated contrast procedures and major surgery as advised. Pancreatitis and severe joint pain have been reported with DPP-4 inhibitors—seek medical help for severe abdominal pain. Monitor blood glucose; risk of hypoglycaemia increases when combined with insulin or sulfonylureas.
